Related Experiment Video
Updated: Jan 25, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Serum Myeloperoxidase, C-reactive Protein and α1-acid Glycoprotein: Insights about Cardiovascular Risk in End-stage
Cristiane Rickli1, Danielle Cristyane Kalva Borato1, Anderson José de Melo E Silva1
1State University of Ponta Grossa - UEPG, Ponta Grossa-PR, Brazil.
Insights
Myeloperoxidase (MPO) levels were evaluated in patients with end-stage renal disease (ESRD). MPO was significantly lower in ESRD patients with cardiovascular disease (CVD), suggesting a potential role as a CVD risk marker.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in end-stage renal disease (ESRD) patients.
- Elevated serum myeloperoxidase (MPO) concentrations are linked to increased CVD risk.
- This study investigates MPO and other biomarkers in ESRD patients with and without CVD undergoing hemodialysis.
Purpose of the Study:
- To evaluate serum MPO levels in individuals with ESRD.
- To compare MPO levels in ESRD patients with and without co-existing CVD.
- To assess other laboratory parameters, including hs-CRP and α1-acid glycoprotein, in these groups.
Main Methods:
- A cohort of 80 volunteers was divided into three groups: control (CON, n=20), ESRD (n=45), and ESRD with CVD (ESRD/CVD, n=15).
- Serum MPO, high-sensitivity C-reactive protein (hs-CRP), and α1-acid glycoprotein were measured.
- Statistical analysis was performed using SPSS 20.0.
Main Results:
- Serum MPO levels were significantly lower in the ESRD/CVD group (21 ng/mL) compared to both the control (84 ng/mL) and ESRD (77 ng/mL) groups (p<0.001).
- hs-CRP and α1-acid glycoprotein levels differed significantly between the ESRD/CVD and control groups (p<0.0001), but not between ESRD and ESRD/CVD groups.
- These findings indicate a distinct MPO profile in ESRD patients with CVD.
Conclusions:
- The study suggests a potential role for MPO as a cardiovascular risk marker in hemodialysis patients with ESRD.
- Further research is recommended to elucidate the precise function of MPO in this population.
- Understanding MPO's role could lead to improved CVD risk stratification and management in ESRD patients.
Background:
Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD). Elevated serum concentrations of myeloperoxidase (MPO) are associated with an increased risk of developing CVD. The objective of this study was to evaluate serum MPO levels, as well as other laboratory parameters, in individuals with ESRD, with and without CVD, undergoing hemodialysis.
Methods:
80 volunteers were admitted, divided into the following groups: control group (CON): 20 individuals without chronic kidney disease (CKD); ESRD group: 45 individuals with CKD stage V and ESRD/CVD group: 15 individuals with CKD stage V and with CVD. The following biomarkers were evaluated: MPO, High sensitivity C-reactive protein (hs-CRP) and α1-acid glycoprotein, following the manufacturer's guidelines in the package inserts. The data were processed through the statistical software SPSS 20.0®.
Results:
The level of MPO for the CON group was 84 ng/mL (73-87 ng/mL), for the ESRD group 77 ng/mL (11-89 ng/mL) and for the ESRD/CVD group 21 ng/mL (8-47 ng/mL), with a significant statistical difference of the ESRD/CVD group from the CON and ESRD groups (p<0.001). For the parameters hs-CRP and α1-acid glycoprotein a statistical difference between the ESRD and ESRD/CVD groups from the CON group (p<0.0001) was observed, but not between the ESRD and ESRD/CVD groups.
Conclusion:
It is suggested that further studies should be performed to define the potential role of MPO as a cardiovascular risk marker for patients with ESRD on hemodialysis.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Relative Reactivity of Carboxylic Acid Derivatives
A key factor in assessing the reactivity of the acid derivatives is the basicity of the substituent or the leaving group. The lower the basicity of the leaving group, the higher the reactivity of the derivative. The basicity of the leaving group follows this order:
Halide ions < Acyloxy ions < Alkoxy ions < Amine ions

